Immunogenicity And Safety Of A Recombinant Adenovirus Type 5 Vectored Covid 19 Vaccine In Healthy Adults Aged 18 Years Or Older A Randomised Double Blind Placebo Controlled Phase 2 Trial The Lancet
www.thelancet.com
South Korea S Genexine Begins Phase I Iia Trials For Covid 19 Vaccine 2020 06 23 Bioworld
www.bioworld.com
Chinese Covid 19 Vaccine Approved To Enter Phase Iii Clinical Trial In Brazil Global Times
www.globaltimes.cn
Phase I Human Clinical Trials Complete India S Covid 19 Vaccine Covaxin Tested On 375 Volunteers
www.dnaindia.com